FDA Adverse Event Other Summary report: N

DYNESYS HA PEDICLE+SET SCREW 6.0X40

MDR report key: 3772270 · Received March 25, 2014

Report

Report Number
9613350-2014-03397
Event Type
Other
Date Received
March 25, 2014
Date of Event
February 28, 2014
Report Date
February 28, 2014
Manufacturer
ZIMMER GMBH
Product Code
NQP
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE MANUFACTURER DID NOT RECEIVE DEVICES FOR REVIEW, AS THE PATIENT IS CURRENTLY BEING MONITORED AND HAS NOT BEEN REVISED TO DATE. THREE X-RAYS AND OTHER SOURCE DOCUMENTS (DYNESIS CATALOGUE NUMBERS, PATIENT INFO REVIEW, DYNESIS RESULT OVERVIEW) WERE RECEIVED. AS NO LOT NUMBERS WERE PROVIDED FOR THE DEVICES, THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED. A CAUSE FOR THIS SPECIFIC EVENT CANNOT BE ASCERTAINED FROM THE INFORMATION PROVIDED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE AND AN INVESTIGATION RESULT BE AVAILABLE, THAT CHANGES THIS ASSESSMENT, AN AMENDE MEDICAL DEVICE REPORT WILL BE SUBMITTED. ANOTHER REPORT IS SUBMITTED FOR THIS COMPLAINT AS 2 DYNESYS HA PEDICLE+SET SCREW 6.4X50 WERE INVOLVED. ZIMMER'S REFERENCE NUMBER OF THIS FILE IS (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT RECEIVED A DYNESYS HA PEDICLE+SET SCREW 6.4X50 ON (B)(6) 2012. CURRENTLY THE PATIENT IS BEING MONITORED. THE FOLLOWING WAS REPORTED. "CORE LAB ANALYSIS OF 12 MONTH POST-OP FILMS SHOWS SUPERIOR L3 COMPRESSION FRACTURE". NO ASSOCIATED ADVERSE EVENT OR SERIOUS ADVERSE EVENT HAS BEEN REPORTED BY THE SITE". "PRIMARY INDICATION FOR INDEX PROCEDURE: SPONDY SECONDARY INDICATION: STENOSIS MEDICAL HX: DIABETES". IT WAS ALSO STATED UNDER THE SUPPORTING DOCUMENTS THAT "THE FRACTURES WERE IDENTIFIED VIA AN OUTSIDE REVIEW OF FILMS AS PART OF THE (B)(4)".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
175301 DYNESYS HA PEDICLE+SET SCREW 6.0X40 DYNESYS SPINAL SYSTEM WITH HA COATED S NQP ZIMMER GMBH UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 82 YR Other